US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Overview
Desktop
Wall Street JournalR
RVNC
Revance Therapeu
5.18
-0.10-1.89%Closed16:02 10/17 EDT
OPEN/PREV CLOSE5.24/5.28
TODAY RANGE5.13-5.28
VOL1.17M
MARKET CAP539.66M
52 WEEK RANGE2.300-9.90
AVG VOL (3M)4.66M
% TURNOVER1.13%
TURNOVER0
P/E (TTM)-1.6139
% RANGE2.84%
EPS(TTM)-3.2096
P/E(FORWARD)-3.6738
P/B-4.1848
BVPS-1.2378
DIVIDEND--
P/S1.947
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP490.25M
SHARES OUTSTANDING104.18M
NEXT EARNINGS11/04-11/19
FREE FLOAT94.64M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·18h ago
Revance Therapeutics (RVNC) Gets a Hold from Mizuho Securities
Seeking Alpha·10/04 13:10
Revance Therapeutics, Crown Labs tender offer extended until Oct. 18
Reuters·10/04 11:35
REVANCE THERAPEUTICS: EXTENDS TENDER OFFER COMMENCEMENT DATE TO OCT 18
NASDAQ·10/03 10:20
Is Inspire Small/Mid Cap ETF (ISMD) a Strong ETF Right Now?
Seeking Alpha·09/26 20:45
Revance Therapeutics: Crown Merger Red Flags Makes For Problematic Call On Shares
Dow Jones·09/23 14:07
Revance Therapeutics Shares Fall on Crown Labs Deal Delay
Seeking Alpha·09/23 11:47
Revance Therapeutics plunges as Crown Labs tender offer delayed amid Teoxane dispute
Reuters·09/23 11:20
REVANCE THERAPEUTICS- CO DENIES ALLEGED MATERIAL BREACHES ASSERTED IN NOTICE
Seeking Alpha·09/21 14:38
Deals this week: Smartsheet, AT&T, BP, Cleveland-Cliffs, Vistra and more
Seeking Alpha·09/17 13:00
Crown Labs tender offer for Revance delayed, expect deal to be completed - analyst
Same Industry
Name/Symbol
Change%
Price